Publications
- Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study2016 | Publication without faculty affiliation
- Diagnosis and treatment of multiple myeloma2014 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Cardiac amyloidosis: A comprehensive review2013 | First Faculty of Medicine
- The five-year successful treatment with lenalidomide - a case report2013 | First Faculty of Medicine
- Treatment of relapsed myeloma with secondary myelodysplasia - a case report2013 | First Faculty of Medicine
- Similar efficacy of thalidomide- and bortezomib-based regimens for first relapse of multiple myeloma2011 | First Faculty of Medicine
- Lenalidomid (Revlimid) in the Treatment of Multiple Myeloma – First Experience in the Czech Republic2008 | First Faculty of Medicine
- Lenalidomid (Revlimid) in the Treatment of Multiple Myeloma – First Experience in the Czech Republic2008 | Publication without faculty affiliation
- Autologous transplantation in 495 multiple myeloma patients - Analysis from the Czech National Registry of Hematopoietic Stem Cell Transplantation2007 | First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- International Staging System required standardization of biochemical laboratory testing in multiple myeloma2006 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
Loading network view...